NCT01652755

Brief Summary

To evaluate the utility of plasma cystatin C(pCysC) as a predictive and diagnostic marker of acute kidney injury(AKI) in patients undergone cardiopulmonary bypass surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

July 26, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 30, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

August 6, 2012

Status Verified

August 1, 2012

Enrollment Period

2.1 years

First QC Date

July 26, 2012

Last Update Submit

August 3, 2012

Conditions

Keywords

cystatin C,acute kidney injury,

Study Arms (2)

AKI group

patients with AKI after cardiopulmonary bypass surgery

non-AKI group

patients without AKI during study period

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients undergone cardiopulmonary bypass surgery

You may qualify if:

  • patients with CPB and admitted to ICU

You may not qualify if:

  • patients with the age \>80 or \<18 years
  • with preexisting renal dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jinhua central hospital

Jinhua, Zhejiang, 321000, China

RECRUITING

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Hongying Ni, MM

    Jinhua Municipal Central Hospital

    STUDY CHAIR

Central Study Contacts

Hongying Ni, MM

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department vice director

Study Record Dates

First Submitted

July 26, 2012

First Posted

July 30, 2012

Study Start

April 1, 2011

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

August 6, 2012

Record last verified: 2012-08

Locations